SM
MRNA icon

STF Management’s Moderna MRNA Stock Holding History

STF Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,527
Closed -$369K – 104
2024
Q3 		$369K Sell
5,527
-490
-8% -$45K 0.17% 92
2024
Q2 		$715K Sell
6,017
-252
-4% -$31.9K 0.3% 66
2024
Q1 		$668K Sell
6,269
-334
-5% -$33.7K 0.29% 75
2023
Q4 		$657K Buy
6,603
+405
+7% +$34.1K 0.31% 71
2023
Q3 		$640K Buy
6,198
+3,805
+159% +$424K 0.34% 67
2023
Q2 		$291K Sell
2,393
-1,969
-45% -$263K 0.31% 59
2023
Q1 		$670K Buy
4,362
+1,802
+70% +$297K 0.45% 43
2022
Q4 		$460K Buy
+2,560
New +$419K 0.66% 35

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

STF Management's MRNA Position: Q4 2024 in Review

STF Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 5,527 shares — an estimated $369K sold.

STF Management first reported a position in MRNA in Q4 2022 and held it in 8 quarters. The position peaked at $715K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • STF Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • STF Management sold 5,527 Moderna shares in Q4 2024, an estimated $369K.
  • STF Management first reported a position in Moderna in Q4 2022 and held it in 8 quarters.
  • STF Management's Moderna position peaked at $715K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on STF Management's 13F filing for Q4 2024, filed 12 Feb 2025.